Navigation Links
New Implantable Device That Can Keep The Heart Ticking

People with a serious heart condition called nonischemic cardiomyopathy may improve their chances of survival if they have a device called a cardioverter-defibrillator implanted in their chests.//

Researchers, assigned about 460 patients with severe cardiomyopathy to receive either standard treatment, with drugs like ACE inhibitors and beta-blockers, or standard treatment plus an implanted defibrillator. A defibrillator is a device that regulates the heart rhythm like a pacemaker, but delivers an electrical jolt to reset the heart if that fails.

Results show those who got the defibrillator were significantly less likely to die. During the initial follow up, 40 people in the standard treatment group passed away, compared to 28 in the defibrillator group. After two years, the mortality rate was about 14 percent in the standard treatment group vs. about 8 percent in the defibrillator group. Significantly, sudden deaths from irregular heartbeats were reduced from 14 in the standard treatment group to just three in the defibrillator group.

Based on their findings researchers however say “the use of these devices should be considered on a case-by-case basis.”
'"/>




Page: 1

Related medicine news :

1. Implantable Contact Lens Found Safe and Effective
2. Making MRIs Safe for Patients With Implantable Heart Devices
3. Implantable devices to be powered by organosilicon compounds in the future
4. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
5. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
6. First Implantable artificial heart gets FDA’s approva
7. Injection supports Heart Devices
8. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
9. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
10. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
11. Making MRIs Safe for Patients With Implantable Heart Devices
Post Your Comments:
(Date:10/10/2008)...More than 600 new Wisconsin,voters can participate...e,result of Aurora Health Care,s voter registratio...ealth care system,s 13 hospitals across Eastern,Wi...t the drives., Aurora employees and volunteers, w...tability Board to serve as special registration de...
(Date:10/10/2008)...nt for behavior change, DES MOINES, Iowa, Oct. 10...cans (51 percent) believe there are good things ab...ges are needed, according to the 2008,EBRI Health ...y the,Employee Benefit Research Institute and Math...tten by the Principal Financial Group(R)., To vie...
(Date:10/10/2008)...NuView Life Sciences Inc.,(NuView) has agreed to a...e), including operations of the linear accelerator...xas. The Trace facility produces,Copper-64, Copper... in,molecular imaging and nuclear medicine. Paul C... confident that by improving operational,efficienc...
(Date:10/10/2008)...wire/ -- Public interest,advocates(1) welcomed the...sions on the threats posed by mercury to human hea... UNEP(2) Open Ended Working Group (OEWG2) on,Mercu...a global framework,on mercury, in preparation for ...where it will be decided whether a global legally-...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Elements for a UN Global Framework on Mercury Agreed to 2
...tal management to offer a pay of nearly $500,000 t...ponse to the above proposal, the Queensland Opposi...onscionable. The popular Aspen Medical Group had ...or for the emergency medicine department, with an ...
...ls in sub-Saharan Africa have joined forces to cre... allow vets// to study for postgraduate degrees wh...Veterinary E-Learning Consortium, launched in earl...vets unable to attend full-time degrees, reported ...
...run all educational and charitable institutions op...istian mission whose head was // detained in conne... and maintains schools, hospitals and orphanages i...ent earlier this month had cancelled the registrat...
...opment Minister today in New Delhi Announced that ...e status under the governments // Total Sanitation...roblem that is not faced only in rural India but a... public bathrooms, a clean sanitation environment,...
Other Medicine News:Health News:Rajasthan Plans To Run Christian Institutions 2Health News:India On The Road To Become 'Open Defecation Free' 2
(Date:10/8/2008)...mab Program to be Discontinued and Headcount to be... its Portfolio Review; Zanolimumab Program to be ...r of Employees, COP...b A/S (OMX: GEN),announced today that it is discon... In addition, as a result of a portfolio review an...
(Date:10/8/2008)... program to evaluate TAXUS(R) Element(TM) Platinum...NATICK, Mass., Oct. 8 /- Bo...nounced that it has completed enrollment in,the PE...ird-generation,TAXUS(R) Element(TM) paclitaxel-elu...has enrolled nearly 1,500 patients at 100 U.S. and...
(Date:10/8/2008)..., Oct. 8 /- Vical Incorporated (Nasda...ata and new nonclinical data,demonstrating that th...pplicable in DNA- and protein-based infectious dis...lain P. Rolland, Pharm.D., Ph.D., Vical,s,Senior V... the data today,Wednesday, October 8, at the Worl...
(Date:10/7/2008)...ct. 7 /- Prometheus Laboratories Inc....ced findings from its,development of PROMETHEUS(R)... irritable bowel syndrome (IBS). The findings sugg...rticular biomarkers in blood samples,between IBS a...iomarkers,combined with a proprietary algorithm, ...
Breaking Medicine Technology:Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Ultrasonic frogs can tune their ears to different frequencies 4146 1Ultrasonic frogs can tune their ears to different frequencies 4146 2Ultrasonic frogs can tune their ears to different frequencies 4146 3Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 1Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 2Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 3Cynosure Receives CE Mark for Smartlipo MPX 28TM 29 Workstation 2678 1Cynosure Receives CE Mark for Smartlipo MPX 28TM 29 Workstation 2678 2Cynosure Receives CE Mark for Smartlipo MPX 28TM 29 Workstation 2678 3Minimally Invasive Treatment Improves Male Fertility 24257 1Minimally Invasive Treatment Improves Male Fertility 24257 2Minimally Invasive Treatment Improves Male Fertility 24257 3
...s, Ace393, the World,s First Commercial Vaccine,fo...ccessfully,Completes Phase I Clinical Trials , ,Tr...genicity , ODENSE, Denmark, March 28, 2007 -ACE Bi...pleased to announce the successful,completion of P...93, the world,s first commercial vaccine for Trave...
...ions Reached in Key Lung Compartments, REINACH and...rstCall/ -- Arpida Ltd. today announced promising,...se radiolabelled,Human Microdose studies included ...ndbreaking study is the first ever using Microdosi... lung compartments.,The results showed that AR-709...
Other Medicine Technology:Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 2Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 3Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5
Unshielded
...s an advanced multi-modality system. The Easy II P...32-channel digital EEG amplifier with seven active... like airflow, respiratory effort and snoring. The...s, a built-in pulse oximeter, and a body position ...
...b Salvage System offers five different products fo... these components are cobalt-chrome, ultra high mo...RDIAN products are extensions of Wright Medical Te...s. , ,The distal femur consists of a rotating hin...
...m features 270 accessibility and the most compact,... diameter available (54 inches). Multichannel imag...r coils, increased patient comfort, and shorter ex...a. , ,The Magnetom C! comes equipped with work...
Medicine Products: